These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 23932516)
21. Cell-division inhibitors: new insights for future antibiotics. Lock RL; Harry EJ Nat Rev Drug Discov; 2008 Apr; 7(4):324-38. PubMed ID: 18323848 [TBL] [Abstract][Full Text] [Related]
22. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522 [TBL] [Abstract][Full Text] [Related]
23. Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials. Paradis-Bleau C; Beaumont M; Sanschagrin F; Voyer N; Levesque RC Bioorg Med Chem; 2007 Feb; 15(3):1330-40. PubMed ID: 17157508 [TBL] [Abstract][Full Text] [Related]
24. The antibiotic resistome: challenge and opportunity for therapeutic intervention. Martínez JL Future Med Chem; 2012 Mar; 4(3):347-59. PubMed ID: 22393941 [TBL] [Abstract][Full Text] [Related]
25. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time? Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283 [TBL] [Abstract][Full Text] [Related]
31. The structure, function, and regulation of Mycobacterium FtsZ. Hong W; Deng W; Xie J Cell Biochem Biophys; 2013 Mar; 65(2):97-105. PubMed ID: 22932926 [TBL] [Abstract][Full Text] [Related]
32. Identification of Pseudomonas aeruginosa FtsZ peptide inhibitors as a tool for development of novel antimicrobials. Paradis-Bleau C; Sanschagrin F; Levesque RC J Antimicrob Chemother; 2004 Jul; 54(1):278-80. PubMed ID: 15190020 [No Abstract] [Full Text] [Related]
33. Alternative natural sources for a new generation of antibacterial agents. Taylor PW Int J Antimicrob Agents; 2013 Sep; 42(3):195-201. PubMed ID: 23796893 [TBL] [Abstract][Full Text] [Related]
34. Bacterial cytoskeleton and implications for new antibiotic targets. Wang H; Xie L; Luo H; Xie J J Drug Target; 2016; 24(5):392-8. PubMed ID: 26548775 [TBL] [Abstract][Full Text] [Related]
35. Bacterial caseinolytic proteases as novel targets for antibacterial treatment. Brötz-Oesterhelt H; Sass P Int J Med Microbiol; 2014 Jan; 304(1):23-30. PubMed ID: 24119566 [TBL] [Abstract][Full Text] [Related]
36. Targeting the bacterial Z-ring. Vollmer W Chem Biol; 2008 Feb; 15(2):93-4. PubMed ID: 18291311 [TBL] [Abstract][Full Text] [Related]
37. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Rai D; Singh JK; Roy N; Panda D Biochem J; 2008 Feb; 410(1):147-55. PubMed ID: 17953519 [TBL] [Abstract][Full Text] [Related]
38. Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ. Czaplewski LG; Collins I; Boyd EA; Brown D; East SP; Gardiner M; Fletcher R; Haydon DJ; Henstock V; Ingram P; Jones C; Noula C; Kennison L; Rockley C; Rose V; Thomaides-Brears HB; Ure R; Whittaker M; Stokes NR Bioorg Med Chem Lett; 2009 Jan; 19(2):524-7. PubMed ID: 19064318 [TBL] [Abstract][Full Text] [Related]
39. Protein-protein complexes as targets for drug discovery against infectious diseases. Akhter Y; Hussain R Adv Protein Chem Struct Biol; 2020; 121():237-251. PubMed ID: 32312423 [TBL] [Abstract][Full Text] [Related]
40. Exploiting current understanding of antibiotic action for discovery of new drugs. Chopra I; Hesse L; O'Neill AJ Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]